Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 85 results found. Search for [ Coronavirus vaccine Sanofi ]

Results 1 to 21 of 85
PTI
May 18, 2021
During a daily virtual press briefing on Monday, the World Health Organisation Director-General said that the surge in COVID-19 cases around the world has compromised the global vaccine supply


PTI
May 18, 2021
China fully understands and is supportive of the developing world's demand for an IPR waiver for COVID-19 vaccines, Chinese Foreign Ministry spokesman Zhao Lijian told reporters in Beijing, without directly referring to India and South Africa's proposal


Reuters
May 17, 2021
Monday's announcement, however, comes as a relief for Sanofi and GSK after they were forced last December to restart their trial and delay the launch of the shot when the vaccine showed a low immune response in older adults as a result of a weak antigen formulation


PB Jayakumar
April 26, 2021
World Health Organisation (WHO)'s data on 'Landscape of candidate vaccines in clinical development' says a total of 91 vaccine candidates have reached the clinical development stage


Associated Press
March 3, 2021
White House press secretary Jen Psaki also announced Tuesday that the federal government was increasing supply of the Moderna and Pfizer vaccines to states next week to 15.2 million doses per week, up from 14.5 million previously


BusinessToday.In
February 24, 2021
Stock Market Updates Today: Sectorally, except for IT and pharma index, all the other indices ended with decent gains. Private, PSU Bank and financial indices closed 3% higher today.


Reuters
February 14, 2021
In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data


BusinessToday.In
January 29, 2021
Last year in September, Novavax had announced its deal with Serum Institute in order to produce 2 billion doses of COVID-19 vaccines


Associated Press
January 8, 2021
Speaking during a news conference in Brussels on Friday, European Commission president Ursula von der Leyen said the agreement will double the amount of doses already ordered by the 27-nation bloc


Manoj Sharma
January 5, 2021
There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine


Associated Press
December 12, 2020
Two vaccine candidates stumbled on Friday in the race among researchers to combat Covid-19, even as the Pfizer jab nears approval in the US


BusinessToday.In
December 11, 2020
Apple Inc has historically had an office-centric culture and Cook has also expressed his desire for staff to ultimately return to the office in several public speaking forums


BusinessToday.In
December 11, 2020
GSK said phase 1/2 interim results showed an immune response comparable to patients who recovered from COVID-19 in adults aged 18 to 49 years but there was an insufficient response in older adults


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


BusinessToday.In
November 4, 2020
COVID-19 vaccine update: Based on the success of the trials and regulatory approvals, we can expect vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious, says SII CEO Adar Poonawalla


PTI
October 31, 2020
The UK is committed to ensuring that everyone at risk of SARS-CoV-2 infection, anywhere in the world, has access to a safe and effective vaccine, said Bingham


BusinessToday.In
October 29, 2020
Coronavirus vaccine: PM Modi said that a digital platform is being created now that will eventually help in enrolling, tracking and reaching beneficiaries


BusinessToday.In
October 29, 2020
Adar Poonawalla claimed there was no immediate concern about the safety of the Oxford vaccine, adding that early indicators have been positive. However, Poonawalla said it will take a year or two to be certain that the vaccine has long-term effect


Reuters
October 28, 2020
The companies said on Wednesday they have signed a statement of intent with vaccine alliance GAVI, which is coordinating the global plan known as COVAX


PAGES 1 OF 5  12345